BUY Cipla Ltd. — Nomura India Research
byNomura India ResearchHorizon: NA (inferred 1 year)26 Oct 2026via Moneycontrol Business (broker lists)
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
Cipla Q2 Results Review: ICICI Securities Remains Bullish After Inline Numbers; Check Target Price
NewsNdtv-Profit·28 Oct · 2w ago
Cipla’s US recovery, biosimilar pipeline key to future growth prospects
NewsEt-Markets·28 Oct · 2w ago
8 other SEBI-registered advisors have active long-term BUY calls on this stock
Advisor consensus · same horizon·28 Oct · 2w ago
Dr Reddy's stock could rise 10-15% if a major biosimilar gets approved in December: Systematix
NewsCnbc-Tv18·27 Oct · 3w ago
Cipla Q2 Results: US sales meet expectations, margins narrow from last year
NewsCnbc-Tv18·27 Oct · 3w ago
Cipla reported unaudited standalone and consolidated financial results for the quarter and half year ended September 30, 2026.
NSE · Outcome of Board Meeting·27 Oct · 3w ago
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·13 Nov · yesterday
Weekly Recap: Cipla Ltd Q2 revenue, profit decline and FDA VAI Verna Goa
NewsGoogle News·2 Nov · 2w ago
3 other SEBI-registered advisors have active long-term SELL calls on this stock
Advisor consensus · same horizon·28 Oct · 2w ago
Cipla Eyes Margin Rebound From FY28 As Middle East Freight Squeeze Hits Q2 Costs
NewsNdtv-Profit·27 Oct · 3w ago
Cipla Q2 net profit falls 35% to Rs 878 crore, revenue dips 2%
NewsEt-Markets·27 Oct · 3w ago
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on Cipla
- BUY — Arun Kumar Mantri13 Nov 2026 · Same day · target ₹1,450 · Expired
- BUY — Rajesh Satpute8 Nov 2026 · Next day · target ₹1,440 · Expired
- BUY — Prakash Gaba4 Nov 2026 · Same day · target ₹1,410 · Expired
- BUY — Kush Bohra3 Nov 2026 · Same day · target ₹1,415 · Expired
- BUY — Rakesh Bansal2 Nov 2026 · Same day · target ₹1,407 · Expired
More from Nomura India Research
- BUY Page Industries13 Nov 2026 · ~1 year · target ₹41,000 · Active
- BUY The Great Eastern Shipping Company12 Nov 2026 · ~1 year · target ₹1,995 · Active
- BUY Max Financial Services12 Nov 2026 · ~1 year · target ₹2,000 · Active
- BUY SBI Life Insurance Company12 Nov 2026 · ~1 year · target ₹2,340 · Active
- BUY Kansai Nerolac Paints11 Nov 2026 · ~1 year · target ₹274 · Active

